Ticagrelor - CISMeF

Preferred Label : Ticagrelor;

MeSH definition : An adenosine triphosphate analogue and reversible P2Y12 PURINORECEPTOR antagonist that inhibits ADP-mediated PLATELET AGGREGATION. It is used for the prevention of THROMBOEMBOLISM by patients with ACUTE CORONARY SYNDROME or a history of MYOCARDIAL INFARCTION.;

MeSH hyponym : AZD6140; AZD-6140;

MeSH CAS label : 1,2-cyclopentanediol, 3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2,3-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-;

UNII : GLH0314RVC;

Details

Origin ID

D000077486;

UMLS CUI

C1999375;

ATC code(s)
- ticagrelor [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Ticagrelor [ICD-11 Extension code]
CISMeF manual mappings
- Ticagrelor (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Ticagrelor [Substance BNPC]
- Ticagrelor [NCIt concept]
- ticagrelor [International Nonproprietary Name]
Pharmacological action(s)
- neurotransmitter agents [MeSH Descriptor]
- platelet aggregation inhibitors [MeSH Descriptor]
- purinergic P2Y receptor antagonists [MeSH Descriptor]
Record concept(s)
- 3-(7-((2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol [MeSH concept]
- AZD 6140 [MeSH concept]
- Brilique [MeSH concept]
- Ticagrelor [MeSH concept]
- brilinta [MeSH concept]
Related MeSH Supplementary Concept(s)
- PB-2452 [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing ticagrelor (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing ticagrelor (medicinal product) [SNOMED CT concept]
- Ticagrelor [NCIt concept]
- Ticagrelor (substance) [SNOMED CT concept]
- ticagrelor [International Nonproprietary Name]
- ticagrelor [ATC Code]
Validated automatic mappings to BTNT
- ticagrelor [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients